Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
Clinical trial NCT05039840 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05039840
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2026-09-03
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.